| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 25th, 2005 | 41 | No |
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 4.63 | -2.28 | -49.63 | 2 | 10 | 1 | 93 | 563.723 | 10 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Indications | antineoplastic | KeyOrganics Bioactives |
| therap | tyrosine kinase inhibitor | MicroSource Spectrum |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.19 | Binding ≤ 10μM |
| AURKC-1-E | Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.20 | Binding ≤ 10μM |
| CDK16-1-E | Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6000 | 0.18 | Binding ≤ 10μM |
| CDKL2-1-E | Cyclin-dependent Kinase-like 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.19 | Binding ≤ 10μM |
| CLK1-2-E | Dual Specificty Protein Kinase CLK1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 630 | 0.21 | Binding ≤ 10μM |
| CLK2-1-E | Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1900 | 0.20 | Binding ≤ 10μM |
| CLK3-1-E | Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9000 | 0.17 | Binding ≤ 10μM |
| CLK4-1-E | Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.20 | Binding ≤ 10μM |
| CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.28 | Binding ≤ 10μM |
| DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.20 | Binding ≤ 10μM |
| EGFR-3-E | Epidermal Growth Factor Receptor ErbB1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 870 | 0.21 | Binding ≤ 10μM |
| EPHB6-1-E | Ephrin Type-B Receptor 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.20 | Binding ≤ 10μM |
| FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9 | 0.27 | Binding ≤ 10μM |
| HIPK4-1-E | Homeodomain-interacting Protein Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.22 | Binding ≤ 10μM |
| IRAK1-1-E | Interleukin-1 Receptor-associated Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2700 | 0.19 | Binding ≤ 10μM |
| IRAK3-1-E | Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 730 | 0.21 | Binding ≤ 10μM |
| KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.29 | Binding ≤ 10μM |
| M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 780 | 0.21 | Binding ≤ 10μM |
| NTRK1-1-E | Nerve Growth Factor Receptor Trk-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 450 | 0.22 | Binding ≤ 10μM |
| NTRK2-1-E | Neurotrophic Tyrosine Kinase Receptor Type 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 740 | 0.21 | Binding ≤ 10μM |
| NTRK3-1-E | NT-3 Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2000 | 0.19 | Binding ≤ 10μM |
| PGFRA-2-E | Platelet-derived Growth Factor Receptor Alpha (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2 | 0.30 | Binding ≤ 10μM |
| PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.28 | Binding ≤ 10μM |
| SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4200 | 0.18 | Binding ≤ 10μM |
| VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.19 | Binding ≤ 10μM |
| VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2070 | 0.19 | Binding ≤ 10μM |
| Z100405-1-O | MV4-11 (Myeloid Leukemia Cells) (cluster #1 Of 1), Other | Other | 60 | 0.25 | Functional ≤ 10μM |
| Z80548-1-O | THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other | Other | 1000 | 0.20 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 630 | 0.21 | Binding ≤ 1μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 210 | 0.23 | Binding ≤ 1μM |
| HIPK4_HUMAN | Q8NE63 | Homeodomain-interacting Protein Kinase 4, Human | 400 | 0.22 | Binding ≤ 1μM |
| IRAK3_HUMAN | Q9Y616 | Interleukin-1 Receptor-associated Kinase 3, Human | 730 | 0.21 | Binding ≤ 1μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 4.9 | 0.28 | Binding ≤ 1μM |
| M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 780 | 0.21 | Binding ≤ 1μM |
| NTRK1_HUMAN | P04629 | Nerve Growth Factor Receptor Trk-A, Human | 200 | 0.23 | Binding ≤ 1μM |
| NTRK2_HUMAN | Q16620 | Neurotrophic Tyrosine Kinase Receptor Type 2, Human | 740 | 0.21 | Binding ≤ 1μM |
| PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 2.4 | 0.29 | Binding ≤ 1μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 200 | 0.23 | Binding ≤ 1μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 120 | 0.24 | Binding ≤ 1μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 170 | 0.23 | Binding ≤ 1μM |
| ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 2500 | 0.19 | Binding ≤ 10μM |
| CDKL2_HUMAN | Q92772 | Cyclin-dependent Kinase-like 2, Human | 2900 | 0.19 | Binding ≤ 10μM |
| CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 1900 | 0.20 | Binding ≤ 10μM |
| CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 9000 | 0.17 | Binding ≤ 10μM |
| CLK4_HUMAN | Q9HAZ1 | Dual Specificity Protein Kinase CLK4, Human | 1600 | 0.20 | Binding ≤ 10μM |
| CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 1400 | 0.20 | Binding ≤ 10μM |
| EPHB6_HUMAN | O15197 | Ephrin Type-B Receptor 6, Human | 1300 | 0.20 | Binding ≤ 10μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 210 | 0.23 | Binding ≤ 10μM |
| DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 1400 | 0.20 | Binding ≤ 10μM |
| HIPK4_HUMAN | Q8NE63 | Homeodomain-interacting Protein Kinase 4, Human | 400 | 0.22 | Binding ≤ 10μM |
| IRAK1_HUMAN | P51617 | Interleukin-1 Receptor-associated Kinase 1, Human | 2700 | 0.19 | Binding ≤ 10μM |
| IRAK3_HUMAN | Q9Y616 | Interleukin-1 Receptor-associated Kinase 3, Human | 730 | 0.21 | Binding ≤ 10μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 3430 | 0.19 | Binding ≤ 10μM |
| M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 2500 | 0.19 | Binding ≤ 10μM |
| NTRK1_HUMAN | P04629 | Nerve Growth Factor Receptor Trk-A, Human | 200 | 0.23 | Binding ≤ 10μM |
| NTRK2_HUMAN | Q16620 | Neurotrophic Tyrosine Kinase Receptor Type 2, Human | 740 | 0.21 | Binding ≤ 10μM |
| NTRK3_HUMAN | Q16288 | NT-3 Growth Factor Receptor, Human | 2000 | 0.19 | Binding ≤ 10μM |
| PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 2.4 | 0.29 | Binding ≤ 10μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 200 | 0.23 | Binding ≤ 10μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 4200 | 0.18 | Binding ≤ 10μM |
| AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 1600 | 0.20 | Binding ≤ 10μM |
| CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 2400 | 0.19 | Binding ≤ 10μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 1100 | 0.20 | Binding ≤ 10μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 170 | 0.23 | Binding ≤ 10μM |
| VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 3100 | 0.19 | Binding ≤ 10μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 2070 | 0.19 | Binding ≤ 10μM |
| Z100405 | Z100405 | MV4-11 (Myeloid Leukemia Cells) | 119 | 0.24 | Functional ≤ 10μM |
| Z80548 | Z80548 | THP-1 (Acute Monocytic Leukemia Cells) | 1000 | 0.20 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| activated TAK1 mediates p38 MAPK activation | |
| ARMS-mediated activation | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| Downstream signal transduction | |
| EGFR downregulation | |
| EGFR interacts with phospholipase C-gamma | |
| EGFR Transactivation by Gastrin | |
| EPH-ephrin mediated repulsion of cells | |
| EPH-Ephrin signaling | |
| EPHA-mediated growth cone collapse | |
| EPHB-mediated forward signaling | |
| Ephrin signaling | |
| Frs2-mediated activation | |
| GAB1 signalosome | |
| GRB2 events in EGFR signaling | |
| GRB2 events in ERBB2 signaling | |
| Integrin cell surface interactions | |
| Interleukin-1 signaling | |
| IRAK1 recruits IKK complex | |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
| MyD88 cascade initiated on plasma membrane | |
| MyD88 dependent cascade initiated on endosome | |
| MyD88:Mal cascade initiated on plasma membrane | |
| Neurophilin interactions with VEGF and VEGFR | |
| NF-kB is activated and signals survival | |
| NGF-independant TRKA activation | |
| NOD1/2 Signaling Pathway | |
| Non-integrin membrane-ECM interactions | |
| p75NTR recruits signalling complexes | |
| PI3K events in ERBB2 signaling | |
| PI3K/AKT activation | |
| PIP3 activates AKT signaling | |
| PLC-gamma1 signalling | |
| PLCG1 events in ERBB2 signaling | |
| Regulation of KIT signaling | |
| Retrograde neurotrophin signalling | |
| SHC1 events in EGFR signaling | |
| SHC1 events in ERBB2 signaling | |
| Signal transduction by L1 | |
| Signaling by constitutively active EGFR | |
| Signaling by EGFR | |
| Signaling by ERBB2 | |
| Signaling by ERBB4 | |
| Signaling by PDGF | |
| Signaling by SCF-KIT | |
| Signalling to p38 via RIT and RIN | |
| Signalling to RAS | |
| Signalling to STAT3 | |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | |
| TRKA activation by NGF | |
| VEGF binds to VEGFR leading to receptor dimerization | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.